₹ 1,533.30
12.50 (0.82%)
2B
Bharat Parenterals
₹ 1,533.30
2Bharat Parenterals Share Price Today
Today Bharat Parenterals opened at 1,545.00 while its previous close was at 1,520.80. In todays trading session BPLPHARMA reached a high of 1,568.80 and low of 1,520.00. The average traded price for today is 1,539.76. The 50 DMA stands at - and 200 DMA is at -. Looking at intraday trend, the stock is moving sideways.
Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.
BPLPHARMA Stock Performance
Markets Today
High
1,568.80
Low
1,520.00
Open at
1,545.00
Prev Close
1,520.80
Volumes
586
Avg Price
1,539.76
Lower Circuit
1,226.70
Upper Circuit
1,839.90
Last Traded Details
Quantity
13
Time
15:24:05
Price Movement
Historical Performance
3 M High
1,649.00
3 M Low
1,125.70
1 Yr High
1,649.00
1 Yr Low
1,125.70
3 Yr High
1,649.00
3 Yr Low
1,125.70
5 Yr High
1,649.00
5 Yr Low
1,125.70
1-Year Performance
BPLPHARMA Pros and Cons
EBITDA for Bharat Parenterals Limited grew from ₹0.03 Cr in Q4 FY26 to ₹6.8 Cr in Q1 FY27 — signaling a strong operational recovery
PAT for the parent company rose from ₹1.3 Cr in Q4 FY26 to ₹3.7 Cr in Q1 FY27 — restoring bottom-line profitability
EBITDA margin expanded from 0.1% in Q4 FY26 to 12.3% in Q1 FY27 — reflecting improved pricing power
Capacity utilization held steady at 21% for Beta-Lactam and 48.5% for General Block from Q4 FY26 to Q1 FY27 — supporting consistent output
Order book remained stable at ₹171 Cr from Q4 FY26 to Q1 FY27 — providing clear visibility for upcoming production
Consolidated PAT widened to -₹3.6 Cr in Q1 FY27 from -₹0.8 Cr in Q4 FY26 — dragging down group profitability
Innoxel Lifesciences PAT loss deepened from -₹7.6 Cr in Q4 FY26 to -₹10.4 Cr in Q1 FY27 — signaling ongoing operational strain
Consolidated EBITDA slipped from ₹1.8 Cr in Q3 FY26 to -₹0.09 Cr in Q1 FY27 — highlighting margin pressure across the group
Consolidated revenue from operations eased from ₹99.6 Cr in Q4 FY26 to ₹93.7 Cr in Q1 FY27 — indicating a slight sales slowdown
Other operating revenue dropped from ₹3.6 Cr in Q4 FY26 to ₹1.1 Cr in Q1 FY27 — reducing supplementary income streams
Get forecast for Price, ROA & ROE based on analyst ratings.
BPLPHARMA Latest News
BPLPHARMA Share Price History
BPLPHARMA Fundamentals
Company Valuation
Market Cap (₹ Cr.)
1,057
PE Ratio
-35.30
PB Ratio
3.28
Dividend Yield
0.07%
ROE
-12.88%
ROCE
-4.89%
Book Value (₹)
467.55
Face Value (₹)
10.00
Analyse BPLPHARMA with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Promoters | 67.19% | 67.19% | 67.19% | 67.17% | 67.20% |
| Domestic Institutional Investors (DII) | 0.54% | 0.54% | 0.54% | 1.06% | 1.37% |
| Foreign Institutional Investors (FII) | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |
| Public Investors | 19.31% | 19.27% | 19.21% | 18.86% | 18.54% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Bharat Parenterals Return Calculator
Note: Past profits do not guarantee future returns.
BPLPHARMA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
BPLPHARMA Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for BPLPHARMA
Margin on BPLPHARMA
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
BPLPHARMA Financials Summary
In Crores
BPLPHARMA Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
| Date | Corporate Action | Information |
|---|---|---|
| 11th Sept 2026, Friday |  Dividend | Final Dividend of ₹1/share |
| 5th Aug 2026, Wednesday |  Stock Result | Q1 FY 26-27 Results  |
| 18th May 2026, Monday | Stock Result | Q4 FY 26-27 Results |
| 30th Jan 2026, Friday | Stock Result | Q3 FY 25-26 Results |
| 12th Nov 2025, Wednesday | Stock Result | Q2 FY 25-26 Results |
The above dates are ex-dates.
Check BPLPHARMA latest Company Filings, Investor Presentation & Conference Call details.
BPLPHARMA Revenue Growth
All values are in Crores
Revenue
Profit
Loss
| Financial Year | Revenue | Revenue Growth | Net Profit | Profit Growth |
|---|---|---|---|---|
| FY 2025-26 | 247 | -22.63% | 16 | -39.44% |
| FY 2024-25 | 319 | 19.79% | 27 | 17.08% |
| FY 2023-24 | 266 | 12.33% | 23 | -7.16% |
Top Mutual Funds Invested in BPLPHARMA
BPLPHARMA Similar Stocks
NSE Indices Today
Open IPOs
What's New In The Market
FAQs on BPLPHARMA
What is the share price of Bharat Parenterals?
What is the 52W high and 52W low of Bharat Parenterals?
What is the return on Bharat Parenterals share?
- Past 1 year: 12.65%
- Past 3 years: 12.65%
- Past 5 years: 12.65%
What is the PE and PB Ratio of Bharat Parenterals?
What is the EPS of Bharat Parenterals?
What is the shareholding pattern of Bharat Parenterals?
- DIIs - 1.37%
- FII - 0.11%
- Promoters - 67.20%
- Public Investors 18.54%
- Goverenment - 0.00%
How to buy Bharat Parenterals shares online?
How to buy Bharat Parenterals shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Bharat Parenterals share
- Tap on “Buy”
